Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Patent
1994-12-23
1999-10-19
Budens, Robert D.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Structurally-modified antibody, immunoglobulin, or fragment...
4241421, 4241541, 5303873, 53038875, A61K 39395, C07K 1628
Patent
active
059685093
ABSTRACT:
An antibody or antibody fragment with a binding affinity for the CD3 antigen, having a human constant region, and human or rat variable framework region, a heavy chain with CDRs having the amino acid sequences:
REFERENCES:
patent: 5225539 (1993-07-01), Winter
Routledge et al. "A humanized monovalent CD3 antibody . . . " Eur. J. Immunol. 21 (1991) pp. 2649-2898.
Clark et al. "The Improved lytic function . . . " Euro. Jour. Immunol. 1989, 19: 381-388.
Rudikoff et al. "Single amino acid . . . " Proc. Natl Acad. of Sci. USA 79:1979-1983. Mar. 1982.
Riechmann et al. "Reshaping human antibodies . . . " Nature 332: 323-377, Mar. 24, 1988.
Verhoeyen et al. "Reshaping human antibodies . . . " Science 239:1534-1536, Mar. 25, 1988.
Queen et al. "A humanized antibody . . . " Proc. Natl Aca. Sci. USA, 86:10029-10033, Dec. 1989.
Cobbold et al. "Therapeutic potential of . . . " Nature 308:460-462, Mar. 29, 1984.
Osband et al. "Problems on the investigational study . . . " Immunology Today 11(6):193-195, 1990.
Waldmann "Monoclonal antibodies in diagnosis and therapy" Science, vol. 252:1657-1662, Jun. 21, 1991.
Dillman, R.O. "Monoclonal antibodies for treating cancer" Annals of Internal Medicine 1989 111:592-603.
Hird et al. "Immunotherapy with monoclonal antibodies" Genes and Cancer, pp. 183-189. Carey et al. Eds. Wiley & Sons Ltd. 1990.
Gorman Scott David
Routledge Edward Graham
Waldmann Herman
BTP International Limited
Budens Robert D.
LandOfFree
Antibodies with binding affinity for the CD3 antigen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies with binding affinity for the CD3 antigen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies with binding affinity for the CD3 antigen will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2052090